Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …

Objective To report clinical and laboratory characteristics, treatment, and clinical outcomes
of patients admitted for neurologic diseases with and without coronavirus disease 2019 (…

We evaluated the effect of DMTs on Covid‐19 severity in patients with MS, with a pooled‐analysis
of two large cohorts from Italy and France. The association of baseline characteristics …

We assess the knowledge available on the difficulties experienced by multiple sclerosis (MS)
patients in work-related activities. A literature review was carried out using the keywords ‘…

Background and Objectives Several studies have assessed risk factors associated with the
severity of COVID-19 outcomes in people with multiple sclerosis (PwMS). The potential role …

This research aims to characterize and compare the protective behaviour of a bio-based
treatment versus benzotriazole (BTA) for the preservation of copper-based artefacts affected by …

The urogenital microbiota is dominated by Lactobacillus that, together with Bifidobacterium,
creates a physiological barrier counteracting pathogen infections. The aim of this study was …

Background IgG antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) define
a subset of associated disorders (myelin oligodendrocyte glycoprotein associated disorders (…

Background: Rituximab, an anti-CD20 monoclonal antibody leading to B lymphocyte depletion,
is increasingly used as an off-label treatment option for multiple sclerosis (MS). Objective…

Results Five hundred and five adult patients with neurological symptoms were evaluated at
the ED starting from 20 February to 30 April 2020. Of these, 147 (29.1%) were found positive …